Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Jennifer M Atkinson"'
Autor:
Jian Zou, Osama Shah, Yu-Chiao Chiu, Tianzhou Ma, Jennifer M Atkinson, Steffi Oesterreich, Adrian V Lee, George C Tseng
Publikováno v:
PLoS Computational Biology, Vol 20, Iss 1, p e1011754 (2024)
Cancer models are instrumental as a substitute for human studies and to expedite basic, translational, and clinical cancer research. For a given cancer type, a wide selection of models, such as cell lines, patient-derived xenografts, organoids and ge
Externí odkaz:
https://doaj.org/article/d6056c710d1441368e8499b836e820b4
Autor:
Jennifer M Atkinson, Kenneth B Rank, Yi Zeng, Andrew Capen, Vipin Yadav, Jason R Manro, Thomas A Engler, Marcio Chedid
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0125028 (2015)
It has previously been observed that a loss of β-catenin expression occurs with melanoma progression and that nuclear β-catenin levels are inversely proportional to cellular proliferation, suggesting that activation of the Wnt/β-catenin pathway ma
Externí odkaz:
https://doaj.org/article/1800f53a19f846dd955aa441443164bd
Autor:
Yang Wu, Zheqi Li, Abdalla M. Wedn, Allison N. Casey, Daniel Brown, Shalini V. Rao, Soleilmane Omarjee, Jagmohan Hooda, Jason S. Carroll, Jason Gertz, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Publikováno v:
Molecular Cancer Research. 21:591-604
Estrogen receptor alpha (ER/ESR1) mutations occur in 30% to 40% of endocrine resistant ER-positive (ER+) breast cancer. Forkhead box A1 (FOXA1) is a key pioneer factor mediating ER–chromatin interactions and endocrine response in ER+ breast cancer,
Abstract P6-14-02: Hope for OTHERS – An organ donation program for metastatic breast cancer research
Autor:
Steffi Oesterreich, Lori Miller, Margaret Q. Rosenzweig, Tanner L. Bartholow, Megan Yates, Ashuvinee Elangovan, Laura Savariau, Allison N. Casey, Nolan Priedigkeit, Kai Ding, Abdalla Wedn, Jie Bin Liu, Daniel D. Brown, Tara Hyder, Geoffrey Pecar, Neil Carleton, Humberto Trejo Bittar, Daniel Geisler, Oscar Lopez-Nunez, Amanda M. Clark, Alan Wells, Partha Roy, Shannon Puhalla, Naomi Howard, Christine Needles, Susan Trent, Stephanie Walker, Christine Hodgdon, Rohit Bhargava, Jennifer M. Atkinson, Adrian V. Lee
Publikováno v:
Cancer Research. 83:P6-14
Background: Previous studies have shown that rapid autopsies (RA) provide a unique opportunity for tissue collection from patients who succumb to the disease. Because cancer patients are unable to donate their organs to other people, this program pro
Autor:
Osama Shiraz Shah, Azadeh Nasrazadani, Jennifer M. Atkinson, Celina Kleer, Priscilla F. McAuliffe, Rohit Bhargava, Jorge Reis-Filho, Peter C. Lucas, ADRIAN V. LEE, Steffi Oesterreich
Publikováno v:
Cancer Research. 83:PD4-07
Background Mixed invasive ductal and lobular carcinoma (mDLC) is a rare special subtype (3-6%, ~10,000 cases/annually in US) of invasive breast cancer with elusive pathophysiology. This entity exhibits a mix of ductal-like and lobular-like tumor sub-
Autor:
Jennifer M. Atkinson, Megan Yates, Daniel D. Brown, Jagmohan Hooda, Rohit Bhargava, Paolo Schiavini, Marianna Zipeto, Steffi Oesterreich, ADRIAN V. LEE
Publikováno v:
Cancer Research. 83:P3-08
Background Most breast cancers (~85%) are of no special histologic subtype (NST), and the most common special subtype is invasive lobular cancer (ILC). ILC accounts for 10-15% of all breast cancers, and there will be ~40,000 new cases in 2022 in the
Autor:
Megan E. Yates, Tiantong Liu, Jagmohan Hooda, Sichun Yang, Riyue Bao, Jennifer M. Atkinson, ADRIAN V. LEE, Steffi Oesterreich
Publikováno v:
Cancer Research. 83:PD10-02
Breast cancer is a leading cause of female mortality and despite advancements in diagnostics and personalized therapeutics, metastatic disease largely remains incurable due to drug resistance. The druggable estrogen receptor (ER, ESR1), overexpressed
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Jason Gertz, Jason S. Carroll, Jagmohan Hooda, Soleilmane Omarjee, Shalini V. Rao, Daniel Brown, Allison N. Casey, Abdalla M. Wedn, Zheqi Li, Yang Wu
Estrogen receptor alpha (ER/ESR1) mutations occur in 30% to 40% of endocrine resistant ER-positive (ER+) breast cancer. Forkhead box A1 (FOXA1) is a key pioneer factor mediating ER–chromatin interactions and endocrine response in ER+ breast cancer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a2ed57172cf4dc081f4403648a1e2b
https://doi.org/10.1158/1541-7786.c.6573877.v1
https://doi.org/10.1158/1541-7786.c.6573877.v1
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Jason Gertz, Jason S. Carroll, Jagmohan Hooda, Soleilmane Omarjee, Shalini V. Rao, Daniel Brown, Allison N. Casey, Abdalla M. Wedn, Zheqi Li, Yang Wu
S1. FOXA1 redistribution in ESR1 mutant cells causes distinct ER-FOXA1 interaction.S2. FOXA1 gained peaks annotated genes are significantly associated with novel target genes.S3. FOXA1 redistribution in ESR1 mutant cells confers potential RXR binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c12d03baf664d3111b46bf66e4ed650
https://doi.org/10.1158/1541-7786.22593319.v1
https://doi.org/10.1158/1541-7786.22593319.v1
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Jason Gertz, Jason S. Carroll, Jagmohan Hooda, Soleilmane Omarjee, Shalini V. Rao, Daniel Brown, Allison N. Casey, Abdalla M. Wedn, Zheqi Li, Yang Wu
Table S1. Data Sets UsedTable S2. FOXA1 and ER Chip-seq peaksTable S3. DE genesTable S4. Enriched FOXA1 peak motifsTable S5. Enriched IPA pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b12dbdcef5cd2915b6960559f5049c
https://doi.org/10.1158/1541-7786.22593316
https://doi.org/10.1158/1541-7786.22593316